Physician profile
Megan Mathew
NPI 1417612060
$1,770.77
in general payments reported to CMS, 2019-2025
11 companies · $1,188 in 2025
The $1,188 reported for 2025 was more than what 87% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $583 · 2025: $1,188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,274 · Travel and Lodging: $470 · Education: $27.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,274.18 |
| Travel and Lodging | $469.59 |
| Education | $27.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $863.67 | 2024-2025 | |
| Endo USA, INC. | $182.94 | 2025 | Xiaflex |
| Boston Scientific Corporation | $167.07 | 2025 | General - Kidney Stone Disease, Lithovue, Axonics |
| Abbvie INC. | $158.26 | 2024 | |
| Medtronic, INC. | $134.95 | 2024 | Interstim |
| Antares Pharma, INC. | $91.23 | 2024-2025 | Xyosted |
| Convatec INC. | $82.38 | 2024 | |
| Endo Pharmaceuticals INC. | $36.31 | 2024 | Xiaflex |
| Laborie Medical Technologies Corp. | $20.16 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Tolmar, INC. | $18.54 | 2025 | Jatenzo, Eligard |
| Sumitomo Pharma America, INC. | $15.26 | 2025 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Mathew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.